These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36292781)

  • 1. Systematic Analysis of Immune Infiltration and Predicting Prognosis in Clear Cell Renal Cell Carcinoma Based on the Inflammation Signature.
    Zhang Y; Shi C; Chen Y; Wang H; Chen F; Han P
    Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma.
    Bao W; Han Q; Guan X; Wang Z; Gu M
    Oncol Res; 2023; 31(2):181-192. PubMed ID: 37304236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
    Gao J; Ye F; Han F; Jiang H; Zhang J
    Front Immunol; 2022; 13():956679. PubMed ID: 36177018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Notch signaling-related lncRNA signature for predicting prognosis and therapeutic response in clear cell renal cell carcinoma.
    Zhang L; Li Y; Cai B; Chen J; Zhao K; Li M; Lang J; Wang K; Pan S; Zhu K
    Sci Rep; 2023 Nov; 13(1):21141. PubMed ID: 38036719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
    Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
    Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoplasmic Reticulum Stress-Related Signature Predicts Prognosis and Drug Response in Clear Cell Renal Cell Carcinoma.
    Zhang Y; Song Y; Dai J; Wang Z; Zeng Y; Chen F; Zhang P
    Front Pharmacol; 2022; 13():909123. PubMed ID: 35959432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome mapping of renal clear cell carcinoma revealed by machine learning algorithm based on enhanced computed tomography images.
    Yang Y; Huang H; Liang H
    J Gene Med; 2023 Jul; 25(7):e3494. PubMed ID: 36869574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma.
    Yin X; Wang Z; Wang J; Xu Y; Kong W; Zhang J
    Oncoimmunology; 2021; 10(1):1933332. PubMed ID: 34262797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an independent immune-genes prognostic index for renal cell carcinoma.
    Li G; Wei X; Su S; Wang S; Wang W; Wang Y; Meng X; Xia J; Song N; Qin C
    BMC Cancer; 2021 Jun; 21(1):746. PubMed ID: 34187413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
    Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
    Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a Lactate-Related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Kidney Renal Clear Cell Carcinoma.
    Sun Z; Tao W; Guo X; Jing C; Zhang M; Wang Z; Kong F; Suo N; Jiang S; Wang H
    Front Immunol; 2022; 13():818984. PubMed ID: 35250999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis-Related Long Noncoding RNA Signature Predicts Prognosis of Clear Cell Renal Carcinoma.
    Liu JW; Supandi F; Dhillon SK
    Folia Biol (Praha); 2022; 68(1):1-15. PubMed ID: 36201853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.
    Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X
    Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
    Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
    J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma.
    Zhang Y; Dai J; Huang W; Chen Q; Chen W; He Q; Chen F; Zhang P
    Aging (Albany NY); 2021 Dec; 13(24):25980-26002. PubMed ID: 34958632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N
    Zhang Y; Yao Y; Qi X; Li J; Liu M; Che X; Xu Y; Wu G
    J Immunol Res; 2021; 2021():6617841. PubMed ID: 33628845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining expression of RNF43 and infiltration level of CD163
    Zhu D; Shi X; Tian Y; Li H; Tang B; Zhang Z; Zhang Z; Zuo L
    Cancer Med; 2023 Feb; 12(4):3962-3971. PubMed ID: 36097369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.